These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29629695)

  • 1. Carnitine Deficiency in Chinese Children with Epilepsy on Valproate Monotherapy.
    Qiliang L; Wenqi S; Hong J
    Indian Pediatr; 2018 Mar; 55(3):222-224. PubMed ID: 29629695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
    Werner T; Treiss I; Kohlmueller D; Mehlem P; Teich M; Longin E; Gerstner T; Koenig SA; Schulze A
    Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
    Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A
    Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine deficiency: Risk factors and incidence in children with epilepsy.
    Fukuda M; Kawabe M; Takehara M; Iwano S; Kuwabara K; Kikuchi C; Wakamoto H; Morimoto T; Suzuki Y; Ishii E
    Brain Dev; 2015 Sep; 37(8):790-6. PubMed ID: 25547040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs.
    Thom H; Carter PE; Cole GF; Stevenson KL
    Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine supplementation in childhood epilepsy: current perspectives.
    De Vivo DC; Bohan TP; Coulter DL; Dreifuss FE; Greenwood RS; Nordli DR; Shields WD; Stafstrom CE; Tein I
    Epilepsia; 1998 Nov; 39(11):1216-25. PubMed ID: 9821988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy.
    Sreedharan M; Devadathan K; Mohammed Kunju PA; Sasidharan B; Pillai JP; Vasumathy Amma MA; Muthubeevi S
    Indian Pediatr; 2018 Apr; 55(4):307-310. PubMed ID: 29428922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium valproate -- induced skeletal myopathy.
    Kasturi L; Sawant SP
    Indian J Pediatr; 2005 Mar; 72(3):243-4. PubMed ID: 15812121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin, lamotrigine, topiramate and serum carnitine levels.
    Zelnik N; Isler N; Goez H; Shiffer M; David M; Shahar E
    Pediatr Neurol; 2008 Jul; 39(1):18-21. PubMed ID: 18555168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine deficiency associated with anticonvulsant therapy.
    Rodriguez-Segade S; de la Peña CA; Tutor JC; Paz JM; Fernandez MP; Rozas I; Del Río R
    Clin Chim Acta; 1989 May; 181(2):175-81. PubMed ID: 2500272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy.
    Røste LS; Taubøll E; Mørkrid L; Bjørnenak T; Saetre ER; Mørland T; Gjerstad L
    Eur J Neurol; 2005 Feb; 12(2):118-24. PubMed ID: 15679699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of subclinical hypothyroidism in ambulatory children with controlled epilepsy on valproate monotherapy.
    Sahu JK; Gulati S; Kabra M; Arya R; Sharma R; Gupta N; Kaleekal T; Reeta Kh; Gupta YK
    J Child Neurol; 2012 May; 27(5):594-7. PubMed ID: 22114214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for sodium valproate-induced renal tubular dysfunction.
    Koga S; Kimata T; Yamanouchi S; Tsuji S; Yoshimura K; Araki A; Kaneko K
    Clin Exp Nephrol; 2018 Apr; 22(2):420-425. PubMed ID: 28836089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine deficiency during valproic acid treatment.
    Van Wouwe JP
    Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.